Mazor Robotics has announced that Adachi Medical Instruments, Mazor’s distribution partner in Japan, placed an order for its Renaissance system. As part of the distribution agreement, Adachi is committed to obtain Japanese PMDA (Pharmaceuticals and Medical Devices Agency) approval for the Renaissance system. The system purchased will be used to facilitate the PMDA process.
Renaissance is a guidance system for spine procedures; it is designed to achieve highly-accurate, procedures, with less radiation even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.
“We are delighted to partner with Mazor to deliver their innovative products to the Japanese market,” said Saburo Adachi, president of Adachi. “We believe strongly in the strength of a mutually beneficial partnership and look forward to working together with Mazor to meet the requirements of the Japanese government to obtain the necessary approvals and deliver this advanced technology to Japan.”
“The distribution agreement and initial purchase order from Adachi signifies an important step in expanding the market for Renaissance in Asia,” said Ori Hadomi, CEO of Mazor. “Adachi is an 80 year-old family-owned business that has established relationships with leading hospitals and medical organisations. It has significant experience in distributing leading medical technology and clearing the regulatory hurdles. We are so pleased to enter the Japanese market with Adachi as our partner.”